CD8A and prostate cancer: For example, through the m6A-PD-L1 axis, the m6A reader YTHDF1 has been shown to reduce ferroptosis and impair CD8+ T cell-mediated anti-tumor immunity in prostate cancer (PCa) (Wang Y. et al., 2024).